Sold as Technetium TC 99M Sulfur Colloid. Every FDA application for this active ingredient.
As of Nov 22, 2026, FDA lists 2 applications for Technetium TC-99M sulfur colloid (sold as Technetium TC 99M Sulfur Colloid), first approved Sep 24, 1974, with 0 new uses approved and 0 published complete response letters.
| Sep 24, 1974 | Technetium TC 99M Sulfur ColloidNDA 17456 ยท New formulation or manufacturer | GE Healthcare | 1 | Discontinued |
| โ | Technetium TC 99M Sulfur ColloidNDA 17724 | Mallinckrodt | 0 | Discontinued |
| Escalating Cycle 1 Dose of Lu-177-PSMA-617 for the Treatment of Metastatic Castration Resistant Prostate CancerMetastatic Castration-Resistant Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8 ยท University of Michigan Rogel Cancer Center | Phase 1 | Not yet recruiting | Jul 6, 2026 |
| Personalized Neck Radiation Therapy Directed by Sentinel Lymph Node Biopsy for the Treatment of Oral Cavity Squamous Cell Carcinoma, PRECEDENT TrialOral Cavity Squamous Cell Carcinoma, Stage I Lip and Oral Cavity Cancer AJCC v8 ยท University of Michigan Rogel Cancer Center | Phase 2 | Recruiting | Aug 13, 2025 |
| Sentinel Lymph Node Biopsy for Cutaneous Squamous Cell Carcinoma of the Head and NeckSquamous Cell Carcinoma, Nonmelanoma Skin Cancer ยท Indiana University | Not applicable | Recruiting | Nov 4, 2021 |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Mechanisms, targets, withdrawals and boxed warnings are from ChEMBL (EMBL-EBI, CC BY-SA 3.0), matched by ingredient name. How trials ended is TrialPanorama's classification of ClinicalTrials.gov records (Wang et al. 2025, Apache-2.0), matched by the intervention name each trial registered. Drugs@FDA